Literature DB >> 27877415

Gd@C82 metallofullerenes for neutron capture therapy-fullerene solubilization by poly(ethylene glycol)-block-poly(2-(N, N-diethylamino)ethyl methacrylate) and resultant efficacy in vitro.

Yukichi Horiguchi1, Shinpei Kudo1, Yukio Nagasaki2.   

Abstract

Poly(ethylene glycol)-block-poly(2-(N,N-diethylamino)ethyl methacrylate) (PEG-b-PAMA) was found to solubilize fullerenes such as C60, and this technique was applied to metallofullerenes. Gd@C82 was easily dissolved in water in the presence of PEG-b-PAMA without any covalent derivatization, forming a transparent complex about 20-30 nm in diameter. Low cytotoxicity was confirmed in vitro. Neutron irradiation of cultured cells (colon-26 adenocarcinoma) with Gd@C82-PEG-b-PAMA-complexed nanoparticles showed effective cytotoxicity, indicating the effective emission of gamma rays and internal conversion electrons produced from the neutron capture reaction of Gd. This result suggests a potentially valuable approach to gadolinium-based neutron capture therapy.

Entities:  

Keywords:  Gd@C82; GdNCT; PEG-b-polyamine; fullerene; in vitro; neutron capture therapy

Year:  2011        PMID: 27877415      PMCID: PMC5090493          DOI: 10.1088/1468-6996/12/4/044607

Source DB:  PubMed          Journal:  Sci Technol Adv Mater        ISSN: 1468-6996            Impact factor:   8.090


  30 in total

1.  Synthesis and physicochemical characterization of Gd-C4-thyroxin-DTPA, a potential MRI contrast agent. Evaluation of its affinity for human serum albumin by proton relaxometry, NMR diffusometry, and electrospray mass spectrometry.

Authors:  C Henoumont; L Vander Elst; S Laurent; R N Muller
Journal:  J Phys Chem B       Date:  2010-03-18       Impact factor: 2.991

2.  A polymeric micelle MRI contrast agent with changeable relaxivity.

Authors:  Emiko Nakamura; Kimiko Makino; Teruo Okano; Tatsuhiro Yamamoto; Masayuki Yokoyama
Journal:  J Control Release       Date:  2006-06-15       Impact factor: 9.776

3.  Chitosan-gadopentetic acid complex nanoparticles for gadolinium neutron-capture therapy of cancer: preparation by novel emulsion-droplet coalescence technique and characterization.

Authors:  H Tokumitsu; H Ichikawa; Y Fukumori
Journal:  Pharm Res       Date:  1999-12       Impact factor: 4.200

4.  Preparation of gadopentetic acid-loaded chitosan microparticles for gadolinium neutron-capture therapy of cancer by a novel emulsion-droplet coalescence technique.

Authors:  H Tokumitsu; H Ichikawa; Y Fukumori; L H Block
Journal:  Chem Pharm Bull (Tokyo)       Date:  1999-06       Impact factor: 1.645

Review 5.  Boron neutron capture therapy of cancer: current status and future prospects.

Authors:  Rolf F Barth; Jeffrey A Coderre; M Graça H Vicente; Thomas E Blue
Journal:  Clin Cancer Res       Date:  2005-06-01       Impact factor: 12.531

6.  In vitro cellular accumulation of gadolinium incorporated into chitosan nanoparticles designed for neutron-capture therapy of cancer.

Authors:  Futoshi Shikata; Hiroyuki Tokumitsu; Hideki Ichikawa; Yoshinobu Fukumori
Journal:  Eur J Pharm Biopharm       Date:  2002-01       Impact factor: 5.571

7.  Engineering tumor-targeted gadolinium hexanedione nanoparticles for potential application in neutron capture therapy.

Authors:  Moses O Oyewumi; Russell J Mumper
Journal:  Bioconjug Chem       Date:  2002 Nov-Dec       Impact factor: 4.774

8.  Neutron-capture therapy of murine ascites tumor with gadolinium-containing microcapsules.

Authors:  Y Akine; N Tokita; K Tokuuye; M Satoh; Y Fukumori; H Tokumitsu; R Kanamori; T Kobayashi; K Kanda
Journal:  J Cancer Res Clin Oncol       Date:  1992       Impact factor: 4.553

9.  Gadolinium neutron capture therapy for brain tumors: a computer study.

Authors:  J T Masiakowski; J L Horton; L J Peters
Journal:  Med Phys       Date:  1992 Sep-Oct       Impact factor: 4.071

10.  Application of boronated anti-CEA immunoliposome to tumour cell growth inhibition in in vitro boron neutron capture therapy model.

Authors:  H Yanagië; T Tomita; H Kobayashi; Y Fujii; T Takahashi; K Hasumi; H Nariuchi; M Sekiguchi
Journal:  Br J Cancer       Date:  1991-04       Impact factor: 7.640

View more
  5 in total

1.  Magnetic resonance imaging, gadolinium neutron capture therapy, and tumor cell detection using ultrasmall Gd2O3 nanoparticles coated with polyacrylic acid-rhodamine B as a multifunctional tumor theragnostic agent.

Authors:  Son Long Ho; Hyunsil Cha; In Taek Oh; Ki-Hye Jung; Mi Hyun Kim; Yong Jin Lee; Xu Miao; Tirusew Tegafaw; Mohammad Yaseen Ahmad; Kwon Seok Chae; Yongmin Chang; Gang Ho Lee
Journal:  RSC Adv       Date:  2018-04-03       Impact factor: 4.036

2.  Trimetallic Nitride Endohedral Fullerenes Carboxyl-Gd3N@C80: A New Theranostic Agent for Combating Oxidative Stress and Resolving Inflammation.

Authors:  Tinghui Li; Li Xiao; Jiezuan Yang; Mengmeng Ding; Zhiguo Zhou; Leslie LaConte; Li Jin; Harry C Dorn; Xudong Li
Journal:  ACS Appl Mater Interfaces       Date:  2017-05-19       Impact factor: 9.229

3.  Isolation and structure determination of missing fullerenes Gd@C74(CF3) n through in situ trifluoromethylation.

Authors:  Ayano Nakagawa; Shinobu Aoyagi; Haruka Omachi; Katsuma Ishino; Makiko Nishino; Jeremy Rio; Chris Ewels; Hisanori Shinohara
Journal:  R Soc Open Sci       Date:  2018-09-19       Impact factor: 2.963

Review 4.  Non-Chromatographic Purification of Endohedral Metallofullerenes.

Authors:  Zhiyong Wang; Haruka Omachi; Hisanori Shinohara
Journal:  Molecules       Date:  2017-04-29       Impact factor: 4.411

Review 5.  Gadolinium Neutron Capture Therapy (GdNCT) Agents from Molecular to Nano: Current Status and Perspectives.

Authors:  Son Long Ho; Huan Yue; Tirusew Tegafaw; Mohammad Yaseen Ahmad; Shuwen Liu; Sung-Wook Nam; Yongmin Chang; Gang Ho Lee
Journal:  ACS Omega       Date:  2022-01-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.